
ZP5 is looking to cure the neglected diseases of the world. ZP5's first candidate (ZP5-9676) is a single-dose therapy intended to treat the major soil-worm transmitted diseases. Soil worm diseases have a disproportionate impact on children living in developing countries.

Investment Details
Funding Round
Series A
Milestones

About the Founder
Joseph Amprey
Amprey has been a professional in healthcare for over 23 years; he has also developed a career as an entrepreneur and venture capitalist. Joseph is utilizing his extensive background in science and business to create a child-friendly treatment for parasites.
Real Investors. Real Outcomes.
Start Your Investing Journey with Portfolia
Our live overview sessions are the best way to experience how Portfolia is transforming venture capital and why the experience is unmatched.
- MEET OUR PARTNERS
- LEARN HOW OUR FUNDS WORK
- SEE THE COMPANIES WE'RE BACKING.


